Skip to main content

bexarotene

Generic: BEXAROTENE·Brand: BEXAROTENE, TARGRETIN, Targretin

bexarotene: 2 clinical trials tracked.

bexarotene evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about bexarotene, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Lung Cancer

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trials (2)

Metastatic Triple-Negative Taxane-Resistant Breast Cancer: Investigating the Role of Bexarotene in Inducing Susceptibility to Chemotherapy by Differentiating Cancer Cells From a Mesenchymal-Like to an Epithelial-Like Phenotype

NCT04664829·Phase 1
Completed

Primary endpoint: Tumour transcriptome by RNA sequencing

Interventionalopen12 enrolledStarted 2020-10Completion 2025-081 site · SingaporeNational Cancer Centre, Singapore

A Phase I/II Study of Bexarotene in Combination With ZD 1839 (IRESSA) in the Third Line Treatment of Non-Small Cell Lung Cancer (NSCLC)

NCT00238628·Phase 1/Phase 2
Completed

Primary endpoint: Overall response rate (RECIST CRITERIA), time to progression, toxicity

Interventionalopen6 enrolledStarted 2004-04Completion 2005-121 site · United StatesStanford University